Everest Medicines Limited (HKG:1952)

Hong Kong · Delayed Price · Currency is HKD

24.88

-0.14 (-0.56%)

Jul 30, 2026, 2:15 PM HKT

Everest Medicines Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,707	1,707	706.68	125.93	12.79	0.05
Revenue Growth	100.48%	141.51%	461.16%	884.46%	23588.89%	-
Gross Profit	1,182	1,182	524.88	91.52	8.15	0.03
Operating Income	-343.89	-343.89	-780.21	-851.27	-1,405	-1,049
Net Income	-297.77	-297.77	-1,041	-844.46	-247.28	-1,009
Earnings Per Share	-0.89	-0.89	-3.24	-2.70	-0.83	-3.44
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,731	2,731	1,604	2,350	1,651	2,640
Total Debt	926.28	926.28	575.61	539.24	534.64	511.81
Net Cash (Debt)	1,805	1,805	1,028	1,810	1,117	2,128
Net Cash Growth	112.14%	75.61%	-43.22%	62.12%	-47.53%	-46.99%
Net Cash Per Share	5.37	5.37	3.20	5.78	3.75	7.26

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-92.56	-92.56	-679.51	-769.19	-1,156	-729.94
Capital Expenditures	-64.01	-64.01	-65.41	-117.34	-355.92	-109.95
Free Cash Flow	-156.57	-156.57	-744.92	-886.53	-1,512	-839.89
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	69.25%	69.25%	74.27%	72.67%	63.69%	57.41%
Operating Margin	-20.15%	-20.15%	-110.41%	-675.97%	-10981.12%	-1943096.30%
Pretax Margin	-35.06%	-35.06%	-147.36%	-670.57%	-1933.04%	-1867998.15%
Profit Margin	-17.45%	-17.45%	-147.36%	-670.57%	-1933.11%	-1867998.15%
FCF Margin	-9.17%	-9.17%	-105.41%	-703.97%	-11817.36%	-1555344.44%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	34.09	95.03	-	-	-	-
PS Ratio	4.63	6.88	20.73	48.28	371.66	155778.93